2025 ICD-10 PCS INDEX TERMS STARTING WITH 3

  • Introduction Female Reproductive to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0P728
  • Introduction Female Reproductive to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0P729
  • Introduction Female Reproductive to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0P73Z
  • Introduction Female Reproductive to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach - 3E0P76Z
  • Introduction Female Reproductive to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach - 3E0P77Z
  • Introduction Female Reproductive to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0P7BZ
  • Introduction Female Reproductive to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0P7GC
  • Introduction Female Reproductive to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0P7HZ
  • Introduction Female Reproductive to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0P7KZ
  • Introduction Female Reproductive to No Qualifier with Sperm, Via Natural or Artificial Opening Approach - 3E0P7LZ
  • Introduction Female Reproductive to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0P7NZ
  • Introduction Female Reproductive to Autologous with Fertilized Ovum, Via Natural or Artificial Opening Approach - 3E0P7Q0
  • Introduction Female Reproductive to Nonautologous with Fertilized Ovum, Via Natural or Artificial Opening Approach - 3E0P7Q1
  • Introduction Female Reproductive to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0P7SF
  • Introduction Female Reproductive to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0P7TZ
  • Introduction Female Reproductive to No Qualifier with Hormone, Via Natural or Artificial Opening Approach - 3E0P7VZ
  • Introduction Female Reproductive to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0P804
  • Introduction Female Reproductive to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0P805
  • Introduction Female Reproductive to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0P80M
  • Introduction Female Reproductive to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0P828
  • Introduction Female Reproductive to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0P829
  • Introduction Female Reproductive to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach - 3E0P83Z
  • Introduction Female Reproductive to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0P86Z
  • Introduction Female Reproductive to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0P87Z
  • Introduction Female Reproductive to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8BZ
  • Introduction Female Reproductive to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8GC
  • Introduction Female Reproductive to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8HZ
  • Introduction Female Reproductive to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8KZ
  • Introduction Female Reproductive to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8NZ
  • Introduction Female Reproductive to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8SF
  • Introduction Female Reproductive to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8TZ
  • Introduction Cranial Cavity and Brain to Liquid Brachytherapy Radioisotope with Antineoplastic, Open Approach - 3E0Q004
  • Introduction Cranial Cavity and Brain to Other Antineoplastic with Antineoplastic, Open Approach - 3E0Q005
  • Introduction Cranial Cavity and Brain to Monoclonal Antibody with Antineoplastic, Open Approach - 3E0Q00M
  • Introduction Cranial Cavity and Brain to Oxazolidinones with Anti-infective, Open Approach - 3E0Q028
  • Introduction Cranial Cavity and Brain to Other Anti-infective with Anti-infective, Open Approach - 3E0Q029
  • Introduction Cranial Cavity and Brain to No Qualifier with Anti-inflammatory, Open Approach - 3E0Q03Z
  • Introduction Cranial Cavity and Brain to No Qualifier with Nutritional Substance, Open Approach - 3E0Q06Z
  • Introduction Cranial Cavity and Brain to No Qualifier with Electrolytic and Water Balance Substance, Open Approach - 3E0Q07Z
  • Introduction Cranial Cavity and Brain to No Qualifier with Stem Cells, Embryonic, Open Approach - 3E0Q0AZ
  • Introduction Cranial Cavity and Brain to No Qualifier with Anesthetic Agent, Open Approach - 3E0Q0BZ
  • Introduction Cranial Cavity and Brain to Autologous with Stem Cells, Somatic, Open Approach - 3E0Q0E0
  • Introduction Cranial Cavity and Brain to Nonautologous with Stem Cells, Somatic, Open Approach - 3E0Q0E1
  • Introduction Cranial Cavity and Brain to Other Substance with Other Therapeutic Substance, Open Approach - 3E0Q0GC
  • Introduction Cranial Cavity and Brain to No Qualifier with Radioactive Substance, Open Approach - 3E0Q0HZ
  • Introduction Cranial Cavity and Brain to No Qualifier with Other Diagnostic Substance, Open Approach - 3E0Q0KZ
  • Introduction Cranial Cavity and Brain to No Qualifier with Analgesics, Hypnotics, Sedatives, Open Approach - 3E0Q0NZ
  • Introduction Cranial Cavity and Brain to Other Gas with Gas, Open Approach - 3E0Q0SF
  • Introduction Cranial Cavity and Brain to No Qualifier with Destructive Agent, Open Approach - 3E0Q0TZ
  • Introduction Cranial Cavity and Brain to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0Q304
  • Introduction Cranial Cavity and Brain to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0Q305
  • Introduction Cranial Cavity and Brain to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0Q30M
  • Introduction Cranial Cavity and Brain to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0Q328
  • Introduction Cranial Cavity and Brain to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0Q329
  • Introduction Cranial Cavity and Brain to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0Q33Z
  • Introduction Cranial Cavity and Brain to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0Q36Z
  • Introduction Cranial Cavity and Brain to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0Q37Z
  • Introduction Cranial Cavity and Brain to No Qualifier with Stem Cells, Embryonic, Percutaneous Approach - 3E0Q3AZ
  • Introduction Cranial Cavity and Brain to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0Q3BZ
  • Introduction Cranial Cavity and Brain to Autologous with Stem Cells, Somatic, Percutaneous Approach - 3E0Q3E0
  • Introduction Cranial Cavity and Brain to Nonautologous with Stem Cells, Somatic, Percutaneous Approach - 3E0Q3E1
  • Introduction Cranial Cavity and Brain to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0Q3GC
  • Introduction Cranial Cavity and Brain to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0Q3HZ
  • Introduction Cranial Cavity and Brain to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0Q3KZ
  • Introduction Cranial Cavity and Brain to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0Q3NZ
  • Introduction Cranial Cavity and Brain to Other Gas with Gas, Percutaneous Approach - 3E0Q3SF
  • Introduction Cranial Cavity and Brain to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0Q3TZ
  • Introduction Cranial Cavity and Brain to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0Q704
  • Introduction Cranial Cavity and Brain to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0Q705
  • Introduction Cranial Cavity and Brain to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0Q70M
  • Introduction Cranial Cavity and Brain to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0Q7SF
  • Introduction Spinal Canal to No Qualifier with Stem Cells, Embryonic, Open Approach - 3E0R0AZ
  • Introduction Spinal Canal to Autologous with Stem Cells, Somatic, Open Approach - 3E0R0E0
  • Introduction Spinal Canal to Nonautologous with Stem Cells, Somatic, Open Approach - 3E0R0E1
  • Introduction Spinal Canal to High-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E0R302
  • Introduction Spinal Canal to Low-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E0R303
  • Introduction Spinal Canal to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0R304
  • Introduction Spinal Canal to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0R305
  • Introduction Spinal Canal to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0R30M
  • Introduction Spinal Canal to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0R328
  • Introduction Spinal Canal to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0R329
  • Introduction Spinal Canal to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0R33Z
  • Introduction Spinal Canal to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0R36Z
  • Introduction Spinal Canal to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0R37Z
  • Introduction Spinal Canal to No Qualifier with Stem Cells, Embryonic, Percutaneous Approach - 3E0R3AZ
  • Introduction Spinal Canal to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0R3BZ
  • Introduction Spinal Canal to Autologous with Stem Cells, Somatic, Percutaneous Approach - 3E0R3E0
  • Introduction Spinal Canal to Nonautologous with Stem Cells, Somatic, Percutaneous Approach - 3E0R3E1
  • Introduction Spinal Canal to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0R3GC
  • Introduction Spinal Canal to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0R3HZ
  • Introduction Spinal Canal to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0R3KZ
  • Introduction Spinal Canal to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0R3NZ
  • Introduction Spinal Canal to Other Gas with Gas, Percutaneous Approach - 3E0R3SF
  • Introduction Spinal Canal to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0R3TZ
  • Introduction Spinal Canal to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0R7SF
  • Introduction Epidural Space to High-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E0S302
  • Introduction Epidural Space to Low-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E0S303
  • Introduction Epidural Space to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0S304
  • Introduction Epidural Space to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0S305
  • Introduction Epidural Space to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0S30M